Business · 05/05/2025Updated: 10/17/2026 · 1 min read
FDA Withdraws Final Guidances on Human Cell and Tissue-Based Products, Reissues as Drafts
Summary
The FDA is withdrawing two final guidances related to reducing the risk of disease transmission from human cells, tissues, and products, and reissuing them as draft guidances.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →